Alcohol and Substance Use Disorders (SUD)
Substance use disorders (SUD) affect millions of Americans and are a major contributor to preventable illness and death. According to the National Institute on Drug Abuse (NIDA), over 46 million people aged 12 or older met the criteria for at least one SUD in 2021, representing nearly 17% of the U.S. population in that age group6. In 2022 alone, over 109,000 drug overdose deaths occurred in the United States, with fentanyl and other synthetic opioids involved in nearly 70% of those fatalities4. In addition, alcohol-related deaths have more than doubled in the past two decades, with alcohol now contributing to more than 1 in 10 deaths among working-age adults5.
High-risk populations include adolescents, older adults, individuals with co-occurring mental health disorders, LGBTQ+ individuals, pregnant and postpartum people, and those with a history of trauma or chronic pain2,3. Youth with untreated anxiety, depression, or ADHD are particularly vulnerable, as early substance use increases the risk of addiction later in life. Among older adults, even moderate alcohol or medication misuse can exacerbate chronic illnesses, increase fall risk, and interact with prescription drugs.
Primary care and behavioral health providers are well-positioned to identify early warning signs of SUD through regular screening, clinical observation, and open dialogue. Evidence-based treatment typically includes a multidisciplinary approach, combining behavioral therapies, family and community support, and medication management when indicated2,3. Close follow-up and coordination of care, especially for patients with complex social or medical needs, are essential to improving outcomes.
- Levy, S. J. L., Williams, J. F., Ryan, S. A., Gonzalez, P. K., Patrick, S. W., Quigley, J., Siqueira, L., Smith, V. C., Walker, L. R., & Committee on Substance Use and Prevention. (2016). Substance use screening, brief intervention, and referral to treatment. Pediatrics, 138(1), e20161211.
- American Academy of Pediatrics. (2021). Substance Use Screening, Brief Intervention, and Referral to Treatment
- American Psychiatric Association. (2023). Practice guideline for the treatment of patients with substance use disorders.
- Centers for Disease Control and Prevention. (2023). Overdose deaths remain high: Provisional data for 2022.
- National Institute on Alcohol Abuse and Alcoholism. (2023). Alcohol-related deaths increased during the pandemic.
- Substance Abuse and Mental Health Services Administration. (2022). Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (NSDUH).
- NIAAA Youth Pocket Guide
- NIAAA Youth Guide a Practitioner's Guide
- Journal of Addiction Medicine: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
- Practice Guideline for the Treatment of Patients with Substance Use Disorders
- The ASAM National Practice Guideline For the Treatment of Opioid Use Disorder
- Substance Use in Lesbian, Gay, and Bisexual Populations: An Update on Empirical Research and Implications for Treatment - PMC
- Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment - PMC
- TIP 26: Treating Substance Use Disorder in Older Adults | SAMHSA Library
| Indication(s) | Pharmacologic class | Common brand names & formulations | Generic name |
| Alcohol Use Disorder Opioid Use Disorder |
Opioid Antagonists |
|
Naltrexone |
| Opioid Use Disorder | Opioid Partial Agonists |
|
Buprenorphine Buprenorphine-naloxone |
| Opioid Use Disorder | Opioid Full Agonists |
|
Methadone |
Want more?
Find help for more behavioral health topics in our provider toolkit.
You are leaving the WellSense website
You are now leaving the WellSense website, and are being connected to a third party web site. Please note that WellSense is not responsible for the information, content or product(s) found on third party web sites.
By accessing the noted link you will be leaving our website and entering a website hosted by another party. Please be advised that you will no longer be subject to, or under the protection of, our privacy and security policies. We encourage you to read and evaluate the privacy and security policies of the site you are entering, which may be different than ours.